Odyssey Therapeutics, Inc. (ODTX) on GreekSoup https://greeksoup.ai/stocks/us/odtx/ Every dated entry in the public record on Odyssey Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Odyssey Therapeutics, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/odtx/filings/us:ODTX:filing:2026-10-20:5bcc017cefTue, 20 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc.: short interest 3,281,824 shares at the 15 October 2026 settlement, 12.38 days to coverhttps://greeksoup.ai/stocks/us/odtx/short-interest/us:ODTX:short-interest:2026-10-15:1be7fc5a95Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc.: short interest 3,105,465 shares at the 30 September 2026 settlement, 5.63 days to coverhttps://greeksoup.ai/stocks/us/odtx/short-interest/us:ODTX:short-interest:2026-09-30:748e847415Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc.: short interest 2,208,686 shares at the 15 September 2026 settlement, 10.78 days to coverhttps://greeksoup.ai/stocks/us/odtx/short-interest/us:ODTX:short-interest:2026-09-15:9237a21d28Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/odtx/filings/us:ODTX:filing:2026-09-09:772fea21feWed, 09 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc.: short interest 2,208,908 shares at the 31 August 2026 settlement, 12.81 days to coverhttps://greeksoup.ai/stocks/us/odtx/short-interest/us:ODTX:short-interest:2026-08-31:e62b8095a8Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc.: short interest 2,249,359 shares at the 14 August 2026 settlement, 18.66 days to coverhttps://greeksoup.ai/stocks/us/odtx/short-interest/us:ODTX:short-interest:2026-08-14:2b96f753ddFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc. Q2 FY2025 results: revenue $959,000, net income -$41 millionhttps://greeksoup.ai/stocks/us/odtx/results/fy2025-q2/us:ODTX:result:2026-08-06:03772dcb15Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc. Q2 FY2026 results: revenue $0, net income -$53 millionhttps://greeksoup.ai/stocks/us/odtx/results/fy2026-q2/us:ODTX:result:2026-08-06:df2d5b005eThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/odtx/filings/us:ODTX:filing:2026-08-06:95ef94ddffThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Odyssey Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/odtx/filings/us:ODTX:filing:2026-08-04:ca41b64fe7Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>